Acute diagnostic biomarkers for spinal cord injury: Review of the literature and preliminary research report

Shoji Yokobori, Zhiqun Zhang, Ahmed Moghieb, Stefania Mondello, Shyam Gajavelli, W. Dalton Dietrich, Helen Bramlett, Ronald L. Hayes, Michael Wang, Kevin K W Wang, Ross Bullock

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Objective Many efforts have been made to create new diagnostic technologies for use in the diagnosis of central nervous system injury. However, there is still no consensus for the use of biomarkers in clinical acute spinal cord injury (SCI). The aims of this review are (1) to evaluate the current status of neurochemical biomarkers and (2) to discuss their potential acute diagnostic role in SCI by reviewing the literature. Methods PubMed (http://www.ncbi.nlm.nih.gov/pubmed) was searched up to 2012 to identify publications concerning diagnostic biomarkers in SCI. To support more knowledge, we also checked secondary references in the primarily retrieved literature. Results Neurofilaments, cleaved-Tau, microtubule-associated protein 2, myelin basic protein, neuron-specific enolase, S100β, and glial fibrillary acidic protein were identified as structural protein biomarkers in SCI by this review process. We could not find reports relating ubiquitin C-terminal hydrolase-L1 and α-II spectrin breakdown products, which are widely researched in other central nervous system injuries. Therefore, we present our preliminary data relating to these two biomarkers. Some of biomarkers showed promising results for SCI diagnosis and outcome prediction; however, there were unresolved issues relating to accuracy and their accessibility. Conclusion Currently, there still are not many reports focused on diagnostic biomarkers in SCI. This fact warranted the need for greater efforts to innovate sensitive and reliable biomarkers for SCI.

Original languageEnglish (US)
Pages (from-to)867-878
Number of pages12
JournalWorld Neurosurgery
Volume83
Issue number5
DOIs
StatePublished - May 1 2015

Fingerprint

Spinal Cord Injuries
Biomarkers
Nervous System Trauma
PubMed
Ubiquitin Thiolesterase
Central Nervous System
Spectrin
Microtubule-Associated Proteins
Myelin Basic Protein
Intermediate Filaments
Phosphopyruvate Hydratase
Glial Fibrillary Acidic Protein
Publications
Technology
Proteins

Keywords

  • Biomarker
  • Pathophysiology
  • Spinal cord injury
  • Treatment

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery

Cite this

Acute diagnostic biomarkers for spinal cord injury : Review of the literature and preliminary research report. / Yokobori, Shoji; Zhang, Zhiqun; Moghieb, Ahmed; Mondello, Stefania; Gajavelli, Shyam; Dalton Dietrich, W.; Bramlett, Helen; Hayes, Ronald L.; Wang, Michael; Wang, Kevin K W; Bullock, Ross.

In: World Neurosurgery, Vol. 83, No. 5, 01.05.2015, p. 867-878.

Research output: Contribution to journalArticle

Yokobori, S, Zhang, Z, Moghieb, A, Mondello, S, Gajavelli, S, Dalton Dietrich, W, Bramlett, H, Hayes, RL, Wang, M, Wang, KKW & Bullock, R 2015, 'Acute diagnostic biomarkers for spinal cord injury: Review of the literature and preliminary research report', World Neurosurgery, vol. 83, no. 5, pp. 867-878. https://doi.org/10.1016/j.wneu.2013.03.012
Yokobori, Shoji ; Zhang, Zhiqun ; Moghieb, Ahmed ; Mondello, Stefania ; Gajavelli, Shyam ; Dalton Dietrich, W. ; Bramlett, Helen ; Hayes, Ronald L. ; Wang, Michael ; Wang, Kevin K W ; Bullock, Ross. / Acute diagnostic biomarkers for spinal cord injury : Review of the literature and preliminary research report. In: World Neurosurgery. 2015 ; Vol. 83, No. 5. pp. 867-878.
@article{e248c50d8924426aba970891c0208e84,
title = "Acute diagnostic biomarkers for spinal cord injury: Review of the literature and preliminary research report",
abstract = "Objective Many efforts have been made to create new diagnostic technologies for use in the diagnosis of central nervous system injury. However, there is still no consensus for the use of biomarkers in clinical acute spinal cord injury (SCI). The aims of this review are (1) to evaluate the current status of neurochemical biomarkers and (2) to discuss their potential acute diagnostic role in SCI by reviewing the literature. Methods PubMed (http://www.ncbi.nlm.nih.gov/pubmed) was searched up to 2012 to identify publications concerning diagnostic biomarkers in SCI. To support more knowledge, we also checked secondary references in the primarily retrieved literature. Results Neurofilaments, cleaved-Tau, microtubule-associated protein 2, myelin basic protein, neuron-specific enolase, S100β, and glial fibrillary acidic protein were identified as structural protein biomarkers in SCI by this review process. We could not find reports relating ubiquitin C-terminal hydrolase-L1 and α-II spectrin breakdown products, which are widely researched in other central nervous system injuries. Therefore, we present our preliminary data relating to these two biomarkers. Some of biomarkers showed promising results for SCI diagnosis and outcome prediction; however, there were unresolved issues relating to accuracy and their accessibility. Conclusion Currently, there still are not many reports focused on diagnostic biomarkers in SCI. This fact warranted the need for greater efforts to innovate sensitive and reliable biomarkers for SCI.",
keywords = "Biomarker, Pathophysiology, Spinal cord injury, Treatment",
author = "Shoji Yokobori and Zhiqun Zhang and Ahmed Moghieb and Stefania Mondello and Shyam Gajavelli and {Dalton Dietrich}, W. and Helen Bramlett and Hayes, {Ronald L.} and Michael Wang and Wang, {Kevin K W} and Ross Bullock",
year = "2015",
month = "5",
day = "1",
doi = "10.1016/j.wneu.2013.03.012",
language = "English (US)",
volume = "83",
pages = "867--878",
journal = "World Neurosurgery",
issn = "1878-8750",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Acute diagnostic biomarkers for spinal cord injury

T2 - Review of the literature and preliminary research report

AU - Yokobori, Shoji

AU - Zhang, Zhiqun

AU - Moghieb, Ahmed

AU - Mondello, Stefania

AU - Gajavelli, Shyam

AU - Dalton Dietrich, W.

AU - Bramlett, Helen

AU - Hayes, Ronald L.

AU - Wang, Michael

AU - Wang, Kevin K W

AU - Bullock, Ross

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Objective Many efforts have been made to create new diagnostic technologies for use in the diagnosis of central nervous system injury. However, there is still no consensus for the use of biomarkers in clinical acute spinal cord injury (SCI). The aims of this review are (1) to evaluate the current status of neurochemical biomarkers and (2) to discuss their potential acute diagnostic role in SCI by reviewing the literature. Methods PubMed (http://www.ncbi.nlm.nih.gov/pubmed) was searched up to 2012 to identify publications concerning diagnostic biomarkers in SCI. To support more knowledge, we also checked secondary references in the primarily retrieved literature. Results Neurofilaments, cleaved-Tau, microtubule-associated protein 2, myelin basic protein, neuron-specific enolase, S100β, and glial fibrillary acidic protein were identified as structural protein biomarkers in SCI by this review process. We could not find reports relating ubiquitin C-terminal hydrolase-L1 and α-II spectrin breakdown products, which are widely researched in other central nervous system injuries. Therefore, we present our preliminary data relating to these two biomarkers. Some of biomarkers showed promising results for SCI diagnosis and outcome prediction; however, there were unresolved issues relating to accuracy and their accessibility. Conclusion Currently, there still are not many reports focused on diagnostic biomarkers in SCI. This fact warranted the need for greater efforts to innovate sensitive and reliable biomarkers for SCI.

AB - Objective Many efforts have been made to create new diagnostic technologies for use in the diagnosis of central nervous system injury. However, there is still no consensus for the use of biomarkers in clinical acute spinal cord injury (SCI). The aims of this review are (1) to evaluate the current status of neurochemical biomarkers and (2) to discuss their potential acute diagnostic role in SCI by reviewing the literature. Methods PubMed (http://www.ncbi.nlm.nih.gov/pubmed) was searched up to 2012 to identify publications concerning diagnostic biomarkers in SCI. To support more knowledge, we also checked secondary references in the primarily retrieved literature. Results Neurofilaments, cleaved-Tau, microtubule-associated protein 2, myelin basic protein, neuron-specific enolase, S100β, and glial fibrillary acidic protein were identified as structural protein biomarkers in SCI by this review process. We could not find reports relating ubiquitin C-terminal hydrolase-L1 and α-II spectrin breakdown products, which are widely researched in other central nervous system injuries. Therefore, we present our preliminary data relating to these two biomarkers. Some of biomarkers showed promising results for SCI diagnosis and outcome prediction; however, there were unresolved issues relating to accuracy and their accessibility. Conclusion Currently, there still are not many reports focused on diagnostic biomarkers in SCI. This fact warranted the need for greater efforts to innovate sensitive and reliable biomarkers for SCI.

KW - Biomarker

KW - Pathophysiology

KW - Spinal cord injury

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=84929306247&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929306247&partnerID=8YFLogxK

U2 - 10.1016/j.wneu.2013.03.012

DO - 10.1016/j.wneu.2013.03.012

M3 - Article

C2 - 23524031

AN - SCOPUS:84929306247

VL - 83

SP - 867

EP - 878

JO - World Neurosurgery

JF - World Neurosurgery

SN - 1878-8750

IS - 5

ER -